With advanced laboratory facilities and an extensive network, ProSTEM actively promotes technological advancements in regenerative therapy.
Infrastructure
ProSTEM operates processing, testing, and cryogenic facilities 24 hours a day and 7 days a week. ProSTEM has a processing laboratory comply with cGMP (current Good Manufacturing Practices) specifications, which pays attention to microbial control, number of particles, room temperature, humidity, light intensity, airflow, and pressure. These monitoring are important to be applied in stem cell processing laboratories because they can affect the quality of stem cells.
Comprehensive Laboratory
The equipment, methods, and procedures employed by ProSTEM are in accordance with the standards set by the American Association of Blood Banks (AABB) and the Foundation of Accreditation of Cellular Therapy – NetCord (FACT-NetCord), which are international standards for the collection, processing, storage, and therapy of stem cells, recognized by the international medical community. Similarly, the laboratory reagents and auxiliary materials selected and used by ProSTEM comply with applicable standards and are registered in Indonesia. Through collaboration with equipment and material suppliers, ProSTEM has the opportunity to be a prioritized company in obtaining up-to-date information regarding advancements in laboratory medical technology and regenerative therapy.
Sample Feasibility Test
ProSTEM collaborates with the Prodia Clinical Laboratory to do screening or sample suitability testing. Prodia Clinical Laboratory has been accredited by national and international bodies, including the National Accreditation Committee (KAN) for ISO 15189, the College of American Pathologists (CAP, USA), and the Royal College of Pathologists Australia (RCPA), guarantee the quality of the tested result.
Laboratory Equipment, Methods and Materials
The equipment, methods, and procedures employed by ProSTEM are in accordance with the standards set by the American Association of Blood Banks (AABB) and the Foundation of Accreditation of Cellular Therapy – NetCord (FACT-NetCord), which are international standards for the collection, processing, storage, and therapy of stem cells, recognized by the international medical community. Similarly, the laboratory reagents and auxiliary materials selected and used by ProSTEM comply with applicable standards and are registered in Indonesia. Through collaboration with equipment and material suppliers, ProSTEM has the opportunity to be a prioritized company in obtaining up-to-date information regarding advancements in laboratory medical technology and regenerative therapy.
Human Resources
ProSTEM has a trained and experienced team who are committed to providing the best quality and service. ProSTEM is active in sharing knowledge and providing input on advances in stem cells by participating as a member and speaker at national and international seminars/congresses. ProSTEM also collaborates with hospitals and clinicians in collecting and administering stem cells. ProSTEM has an in vitro research facility to provide research in cell morphology, cell identity, and content identification such as protein. Our experts are ready to support specialist doctors/researchers in conducting stem cell research and therapy in Indonesia.
